Summary
Complex interactions among constituents of blood and components of the vessel wall are involved in the pathogenesis of atherosclerosis and its subsequent thrombotic complications. Alterations in the endothelium are central both to the slowly progressive process of atherogenesis and to the acute events leading to thrombotic occlusion. Recent data, obtained by systematic evaluation of chronologic events that occur in diet-induced atherosclerosis, have extended our understanding of interactive processes among endothelium, monocytes, platelets, vascular smooth muscle cells, and humoral hemostatic elements in atherogenesis.
Similar content being viewed by others
Abbreviations
- ADP:
-
adenosine diphosphate
- APC:
-
activated protein C
- AT III:
-
antithrombin III
- FDP:
-
fibrin(ogen) degradation products
- GP:
-
glycoprotein
- LDL:
-
low density lipoprotein
- PA:
-
plasminogen activator
- PAI:
-
plasminogen activator inhibitor
- PDGF:
-
platelet-derived growth factor
- PF 4:
-
platelet factor 4
- PGI2 :
-
prostacyclin
- T: AT III:
-
thrombinantithrombin III complex
- βTG:
-
β-thromboglobin
- TNF:
-
tumor necrosis factor
- TXA2 :
-
thromboxane A2
- vWF:
-
von Willebrand factor
References
Bachmann F, Kruithof EKO (1984) Tissue plasminogen activator: chemical and physiological aspects. Semin Thromb Hemost 10: 6–17
Bowen-Pope DF, Vogel A, Ross R (1984) Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents. Proc Natl Acad Sci USA 81: 2396–2400
Collen D, Lijnen HR (1986) The fibrinolytic system in man. CRC Crit Rev Oncol Hematol 4: 249–301
Erickson LA, Schleef RR, Ny T, Loskutoff DJ (1985) The fibrinolytic system of the vascular wall. Clin Haematol 14: 513–530
Faggiotto A, Ross R, Harker LA (1984) Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 4: 323–340
Faggiotto A, Ross R (1984) Studies of hypercholesterolemia in nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis 4: 341–356
George JN, Nurden AT, Phillips DR (1984) Molecular defects in interactions of platelets with the vessel wall. N Engl J Med 311: 1084–1098
Harker LA, Ross, R, Slichter SJ, Scott C (1976) Homocystine-induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genesis. J Clin Invest 58: 731–741
Harker LA, Schwartz SM, Ross R (1981) Endothelium and arteriosclerosis. Clin Haematol 10: 283–296
Harker LA (1986) Platelets, endothelial injury, and atherosclerosis. In: Steinberg D, Olefsky JM (eds) Contemporary Issues in Atherosclerosis. Churchill Livingstone, Edinburgh, New York, pp 25–52
Harker LA (1987) Endothelium and Hemostasis. In: Ryan US (ed) Endothelial cells. CRC Press, Boca Raton (in press)
Harlan JM, Harker LA (1983) Thrombosis and coronary artery disease. Current Concepts, Upjohn, Kalamazoo
Levine JD, Harlan JM, Harker LA, Joseph ML, Counts RB (1982) Thrombin-mediated release of factor VIII antigen from human umbilical vein endothelial cells in culture. Blood 60: 531–534
Majerus PW, Miletich JP, Kane WH, Hofmann SL (1980) The formation of thrombin on platelet surface. In: Mann KG, Taylor FB Jr (eds) The regulation of coagulation. Elsevier North Holland, New York, pp 215–224
McGill HC Jr (1984) Persistant problems in the pathogenesis of atherosclerosis. Arteriosclerosis 4: 443–451
Nawroth PP, Kisiel W, Stern DM (1985) The role of endothelium in the homeostatic balance of haemostasis. Clin Haematol 14: 531–546
Nawroth PP, Handley DA, Esmon CT, Stern DM (1986) Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA 83: 3460–3464
Nawroth PP, Stern DM (1986) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163: 740–745
Nesheim ME, Hibbard LS, Tracy PB (1980) Participation of factor Va in prothrombinase. In: Mann KG, Taylor FB Jr (eds) The regulation of coagulation. Elsevier, North Holland, New York, pp 145–159
Nieuwenhuis HK, Akkermann JWW, Houdijk WPM, Sixma JJ (1985) Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 318: 470–472
Niewiarowski S, Rao AK (1983) Contribution of thrombogenic factors to the pathogenesis of atherosclerosis. Prog Cardiovasc Dis 26: 197–221
Plow EF (1986) The contribution of leukocyte proteases to fibrinolysis. Blut 53: 1–9
Reidy MA, Yoshida K, Harker LA, Schwartz SM (1986) Vascular injury: quantification of experimental focal endothelial denudation in rats using Indium-111-labeled platelets. Arteriosclerosis 6: 305–311
Rosenberg RD (1985) Role of heparin and heparinlike molecules in thrombosis and atherosclerosis. Federation Proc 44: 404–409
Ross R, Glomset JA (1976) The pathogenesis of atherosclerosis. N Engl J Med 295: 369–377, 420–425
Ross R, Harker LA (1976) Hyperlipidemia and atherosclerosis: chronic hyperlipidemia induces lesion initiation and progression by endothelial cell desquamation and lipid accumulation. Science 193: 1094–2000
Ross R (1981) Atherosclerosis: a problem of the biology of arterial wall cells and their interaction with blood components. Arteriosclerosis 1: 293–311
Ross R (1983) Atherosclerosis: a question of endothelial integrity and growth control of smooth muscle. In: The Harvey Lectures, Series 77. Academic Press, New York, pp 161–182
Ross R (1986) The pathogenesis of atherosclerosis — an update. N Engl J Med 314: 488–500
Scharf RE (1986) Die Rolle der Blutplättchen bei Mikrozirkulationsstörungen. In: Scharf RE, Thrombozyten und Mikrozirkulationsstörungen. Klinische und experimentelle Untersuchungen zum Sekretionsverhalten und Arachidonsäurestoffwechsel der Blutplättchen. Schattauer, Stuttgart, New York, pp 213–220
Schwartz SM, Gajdusek CM (1983) Growth factors and the vessel wall. Prog Thromb Hemost 6: 85–112
Simionescu M, Simionescu N (1986) Functions of the endothelial cell surface. Ann Rev Physiol 48: 279–293
Stern DM, Drilling M, Kisiel W, Nawroth PP, Nossel HL, La Gamma KS (1984) Activation of factor IX bound to cultured bovine aortic endothelial cells. Proc Natl Acad Sci USA 81: 913–917
Vague P, Juhan-Vague I, Aillaud MF, Badier C, Viard R, Alessi MC, Collen D (1986) Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism 35: 250–253
Verstraete M, Collen D (1986) Thrombolytic therapy in the eighties. Blood 67: 1529–1541
Weimar B, Delvos U (1986) The mechanism of fibrin-induced disorganization of cultured human endothelial cell monolayers. Arteriosclerosis 6: 139–145
Del Zoppo GJ, Harker LA (1984) Blood/vessel interaction in coronary disease. Hosp Pract 19: 163–182
Author information
Authors and Affiliations
Additional information
This work was supported in part by the Deutsche Forschungsgemeinschaft (grant Scha 358/1–2) and the National Institutes of Health (grants HL 31950 and RR 00833)
Rights and permissions
About this article
Cite this article
Scharf, R.E., Harker, L.A. Thrombosis and atherosclerosis: Regulatory role of interactions among blood components and endothelium. Blut 55, 131–144 (1987). https://doi.org/10.1007/BF00320567
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00320567